Objective: To compare and analyze the differences in vaginal microecological characteristics between populations with ...

JAY-Z’s bid for a Times Square casino, a partnership with Roc Nation and Caesars, was disapproved The decision was a victory for community groups who opposed the project’s impact on Broadway The vote ...

L. MACUNGIE TWP., Pa. – The Lower Macungie Township Board of Commissioners tabled a conditional use hearing for a proposed commercial development project Thursday night at the administration building.

Dyne Therapeutics Inc. (NASDAQ:DYN) is one of the high short interest stocks to buy right now. On December 8, Dyne Therapeutics announced positive topline results from the Registrational Expansion ...

A former server shared a side-by-side look at how boomers and Gen Z leave their tables after a meal, and the comparison stirred up a huge debate. People argued about respect, empathy, and whether ...

Gen Z is bringing back a controversial dining trend, a new report found, as the generation seeks connection in an increasingly digital world. Members of the generation born between 1997 and 2012 are ...

The bobcat was caught and then tested in Waycross. GCHD is warning people to avoid contact with wild animals and for pet owners to keep their animals up to date on rabies vaccinations. Anyone who is ...

The Mexican police block protesters gathered on Paseo de la Reforma as they head toward Mexico City’s Zocalo. The protest, led by members of "Gen Z," referring to those under 28, initially erupted on ...

The CEO of Genvid — the company behind choose-your-own-adventure interactive series like Silent Hill Ascension — has claimed "consumers generally do not care" about generative AI in games, stating: ...

Zymeworks Inc. (ZYME) surged after positive Phase 3 results for Ziihera in first-line HER2-positive gastroesophageal adenocarcinoma, expanding its FDA-approved indications. ZYME's partnership-driven ...

(RTTNews) - Zymeworks Inc. (ZYME) surged 30.02% to $24.08, up $5.56, after announcing positive topline results from its Phase 3 HERIZON-GEA-01 trial evaluating Ziihera (zanidatamab-hrii) with ...